Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Deloitte
Queensland Health
Fuji
McKinsey
Boehringer Ingelheim
Healthtrust
Baxter
Citi

Generated: April 26, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 076894

« Back to Dashboard

NDA 076894 describes TORSEMIDE, which is a drug marketed by Luitpold, West-ward Pharms Int, Apotex Inc, Aurobindo Pharma, Hetero Labs Ltd Iii, Par Pharm, Pliva Pharm Ind, Sun Pharm Inds, Teva, and Vintage Pharms, and is included in eleven NDAs. It is available from seventeen suppliers. Additional details are available on the TORSEMIDE profile page.

The generic ingredient in TORSEMIDE is torsemide. There are sixteen drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the torsemide profile page.
Summary for 076894
Tradename:TORSEMIDE
Applicant:Apotex Inc
Ingredient:torsemide
Patents:0
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 076894
Suppliers and Packaging for NDA: 076894
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TORSEMIDE torsemide TABLET;ORAL 076894 ANDA Apotex Corp. 60505-0232 N 60505-0232-1
TORSEMIDE torsemide TABLET;ORAL 076894 ANDA Apotex Corp. 60505-0232 N 60505-0232-2

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength5MG
Approval Date:May 31, 2005TE:ABRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength10MG
Approval Date:May 31, 2005TE:ABRLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength20MG
Approval Date:May 31, 2005TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Deloitte
AstraZeneca
Julphar
Harvard Business School
Daiichi Sankyo
Boehringer Ingelheim
Cipla
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.